CLNN SCHEDULE 13G/A: SEC filing
Clene Inc.
Filed with the SEC on · accession 0001213900-26-089980
CLNN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Clene Inc. filed an amended Schedule 13G indicating a passive institutional holder's updated ownership position. The stock moved -1.2% by the first close after the filing.
Summary of the filing
Clene Inc. filed an amended Schedule 13G indicating a passive institutional holder's updated ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Key details
How CLNN stock reacted
Close before
$4.19
Aug 13, 2026
First close after
-1.19%
$4.14
5 trading days
+3.58%
$4.34
Since filing
-5.73%
$3.95
✦ Ask GOAX AI about this filing — what it means for CLNN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLNN?
Click hereFrequently asked questions
What did CLNN file with the SEC on Aug 14, 2026?
CLNN filed a SCHEDULE 13G/A (SEC filing). Clene Inc. filed an amended Schedule 13G indicating a passive institutional holder's updated ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CLNN stock react to this filing?
CLNN closed at $4.19 before the filing and $4.14 on Aug 14, 2026 (-1.19%). Five trading days later: $4.34 (+3.58%).
Other CLNN SEC filings
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- 8-K · Material agreementOct 20, 2026
- 8-K · Fda approvalOct 19, 2026
- SCHEDULE 13G/A · SEC filingOct 13, 2026
- 8-K · Secondary offeringSep 16, 2026
- 424B5 · Secondary offeringSep 16, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 11, 2026
Get alerts when CLNN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days